TXMD
TherapeuticsMD, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.82
+2.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 10.71x
- P/E 2027E
- 9.58x
- P/E 2028E
- —
- P/S forward
- 0.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.78x
- Price / sales
- 6.44x
- Price / cash flow
- 6.75x
Enterprise value
- Enterprise value
- $17.4M
- EV / sales
- 5.33x
- EV / EBITDA
- -4.40x
- EV / EBIT
- -4.53x
- Market cap
- $21.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026